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A B S T R A C T
Basal cell carcinoma (basalioma, BCC) is undoubtedly the most common malignant skin cancer and the most com-
mon human malignancy in general, with the continuous increase in its incidence. BCC is generally a disorder of white
individuals, especially those with fair skin. UV radiation is the most important risk factor in the development of BCC.
Short-wavelength UVB radiation (290–320 nm, sunburn rays) is believed to play a greater role in BCC formation than
long-wavelength UVA radiation (320–400 nm, tanning rays). A latency period of 20–50 years is typical between the time
of UV damage and the clinical onset of BCC. Therefore, in most cases BCC develops on chronically sun-exposed skin in
elderly people, most commonly in the area of head and neck. UVB radiation damages DNA and its repair system and al-
ters the immune system resulting in a progressive genetic alterations and formation of neoplasm. UV-induced mutations
in the TP53 tumor-suppressor gene have been found in about 50% of BCC cases. The mutations that activate the Hedge-
hog intercellular signaling pathway genes, including PTCH, Sonic hedgehog (Shh) and Smoothened (Smo) play a sig-
nificant role in cutaneous carcinogenesis. Epidemiologic studies demonstrate the higher incidence of the BCC in more
equatorial latitudes than in polar latitudes. Other risk factors for the development of BCC include sun bed use, family
history of skin cancers, skin type 1 and 2, immunosuppression, previous radiotherapy, and chronic exposure to toxic sub-
stances such as inorganic arsenic. Although rarely metastatic, its malignant nature is sometimes emphasized by the lo-
cal tissue destruction, disfigurement, and even death if left untreated. Due to extremely high incidence of BCC medical
professionals should be aware of the importance of the public education on the etiology of this tumor and the importance
of the UV protection.
Key words: basal cell carcinoma, basalioma, UV radiation, photoimmunology, carcinogenesis
Introduction
Basal cell carcinoma (BCC) is a malignant epidermal
neoplasm which usually develops on chronically photo-
-exposed areas of the skin in elderly people, most fre-
quently on the head and neck. BCC is the most common
of all cancers and it accounts for approximately 80% of all
skin cancers1. This type of skin tumor is more common in
male than in female patients and it is rarely observed in
darkly pigmented patients. Published epidemiological data
has shown worldwide increasing incidence of BCC at a
rate of 3–10% per year. With respect to increased inci-
dence of this rarely life-threatening tumor, BCC has be-
come a significant public health issue2. The incidence
rates of BCC have increased in Europe, USA and Austra-
lia over the past several decades3,4. The similar trend has
been observed in Croatia. The exact incidence and mor-
tality rates of BCC in Croatia are unknown since they are
not routinely reported into the National Cancer Register.
Various etiological factors are involved in the occurrence
of the disease, predominantly associated with UV radia-
tion, particularly solar UVB radiation. It represents the
most significant environmental risk factor for the devel-
opment of non-melanoma skin cancer (NMSC) in hu-
mans5,6. During the past century, changes in clothing
styles, recreational activities, chronic occupational solar
exposure, longevity, and other aspects of lifestyle have re-
sulted in increased exposure to sunlight7. Although most
ultraviolet radiation comes from the sun, the use of sun
beds as artificial sunlight has resulted in a rising inci-
dence of ultraviolet-induced skin cancers. A history of
previous irradiation or trauma to skin areas, immuno-
167
Received for publication July 30, 2006
suppression, or exposure to inorganic arsenicals is also
well-known predisposing factor for this form of skin
cancer8. Multiple BCCs can rarely be hereditary. In-
herited conditions with multiple BCCs include: Nevoid
Basal Cell Carcinoma Syndrome (Gorlin-Goltz syndrome
with multiple BCCs, palmar and plantar pits, odonto-
genic keratocysts of the jaw, skeletal abnormalities, and
calcification of the falx cerebri), Bazex syndrome (follicu-
lar atrophoderma, hypotrichosis, localized hypohidrosis,
milia, epidermoid cysts, and the early onset of multiple
primarily facial, BCCs), Rombo syndrome (atrophoder-
ma vermiculatum, hypotrichosis, blepharitis, milia, pe-
ripheral vasodilation with cyanosis, and BCCs), and uni-
lateral basal cell nevus syndrome7,9. Despite the low
mortality rate, BCCs can cause substantial morbidity
and cosmetic disfigurement, with strong impact on health
care budgets due to their extraordinary high incidence10.
UV Radiation and BCC
Solar, non-ionizing, ultraviolet electromagnetic waves
are well-known, potent, environmental carcinogenic agent
closely associated with the development of skin cancer in
fair-skinned adults11. The concept of the UV radiation as
the major etiologic agent in the pathogenesis of NMSC
originates from the beginning of the twentieth century
followed by astute observations of physicians who noted
that skin cancers frequently appeared on the sun-dam-
aged skin of persons who pursued outdoor occupations.
Thus sunlight was one of the first agents recognized to
be carcinogenic for humans12. Since then numerous epi-
demiological studies have supported the notion that UV
radiation causes skin cancer. The most convincing fact is
the predominant appearance of these cancers on chroni-
cally photo-exposed areas including the face, head, and
neck. Within the ultraviolet radiation spectrum, the ul-
traviolet A (wavelengths between 320 and 400 nm) and
particularly ultraviolet B wavebands (wavelengths be-
tween 290 and 320 nm) are the most significant, as ultra-
violet C (wavelengths between 200 and 290 nm), is mainly
filtered out by the ozone layer in the upper atmosphere.
Only one per cent of UVB does reach the surface of the
earth. Published experimental studies have suggested
that stratospheric ozone layer has been decreasing since
1980 due to higher concentration of chlorofluorocarbon
agents from everyday use products7. The ozone layer de-
pletion and increased cumulative UV radiation exposure
due to prolonged lifespan may account for the enhanced
risk of skin cancer11. Geographically, there is a direct as-
sociation between the amount of environmental solar ra-
diation and the incidence of skin cancer in fair-skinned
population. However, it is important to mention that the
incidence of squamous cell carcinoma is more dependent
on sunlight exposure than BCC indicating that other fac-
tors, in addition to sunlight may be responsible for the
development of BCC. According to several epidemiologic
studies, the incidence of BCC poorly correlates with cu-
mulative lifetime sun exposure and may be more related
to intermittent (recreational) exposure and exposure du-
ring the childhood13. Additionally, a more recent cohort
study with 966 individuals (Kennedy et al.) investigated
environmental and genetic risk factors for skin cancer.
Their results showed the association of painful sunburns
before the age of 20 with all three types of NMSC as well
as actinic keratosis. Therefore, cumulative lifetime sun
exposure was associated with an increased risk of squa-
mous cell carcinoma (SCC) and actinic keratosis and to a
lesser degree with BCC14.
Large epidemiological studies have shown that recre-
ational activities such as sun exposure on the beach or
during water sports are associated with an increased risk
of BCC, whereas skiing has shown association with at in-
creased risk of SCC. Yet, spectators at outdoor sporting
events are often unaware of sun exposure risk15. Besides
occupational and recreational UV exposure, UV photo-
therapy has also been associated with carcinogenic po-
tential. A study conducted by Lim and Stern investigated
UVB versus PUVA risk. Although UVB exposure appears
to increase the risk of non-melanoma skin cancer, the at-
tributable risk ratio per treatment of PUVA is seven
times higher than for UVB for both SCC and BCC, sug-
gesting that the carcinogenic risk of a single PUVA treat-
ment is about seven times higher than for a single UVB
treatment. Their results demonstrated that large num-
ber of UVB treatments (more than 300) confers modest
but significantly increased risk of NMSC in adults. Thus,
the modest risk associated with UVB therapy must be
considered in the context of a patient’s underlying skin
cancer risk and against the benefits of therapy16.
Carcinogenesis in BCC
UV radiation damages DNA and its repair system and
alters the immune system resulting in a progressive ge-
netic alterations and formation of neoplasms. Carcino-
genesis in BCC involves multiple events in the cell cy-
cle17. UVB radiation is absorbed by the nuclear DNA, the
most important endogenous chromophore. Absorption of
UVB by nucleotides causes the formation of pyrimidine
dimers leading to mutations in the tumor suppressor
genes p53 and Patched-1 (PTCH1). UV radiation is in-
volved in the mutations of the Hedgehog (HH)/Patched
(PTCH)/Gli intercellular signaling pathway genes, in-
cluding PTCH, sonic hedgehog (SHH) and smoothened
(Smo). The HH family of intercellular signaling proteins
have crucial role in the signal transduction pathways in
embryonic development. However, HH pathway can also
play an important role in cutaneous carcinogenesis and,
it has been recognized that the SHH pathway is impli-
cated in the etiology of BCC. Mutations in the receptor of
SHH, PTCH gene, have been characterized in both, spo-
radic BCCs and in BCC of patients with rare genetic syn-
dromes such as Gorlin-Goltz syndrome and Xeroderma
pigmentosum. Delineation of the biochemical pathway in
which PTCH functions may lead to medical therapy for
skin cancers, and possibly other malignancies. The SHH
signaling is activated by the binding of the SHH protein
to the PTCH membrane receptor, which is a tumor sup-
M. [itum et al.: UV Radiation and Basal Cell Carcinoma, Coll. Antropol. 32 (2008) Suppl. 2: 167–170
168
pression protein. PTHC inhibits the expression of HH
target genes – glioma transcription factor-1 (Gli-1) and
PTCH-1 which are involved in cell proliferation. The
third component of the SHH pathway is the transmem-
brane protein Smoothened (Smo). In the absence of Shh,
PTCH inhibits Smo which results in the blocking of tar-
get genes. On the other hand, binding of HH to PTCH
suspends the inhibitory effect of PTCH on its signaling
partner Smo18. It is clear that the disruption of the
intercellular HH signaling pathway is closely linked to
the development of BCC. However, specific UV induced
mutations can be found only in approximately 50% of
sporadic BCCs. Thus, cumulative UVB radiation cannot
be considered to be single etiologic risk factor for BCC
development19. In addition, about 50% of BCC cases
carry mutations in the p53 tumor suppressor gene. Tu-
mor suppressor genes, p53 and PTCH1, are cell cycle reg-
ulators, regulating G1/S phase cell cycle progression, and
also in charge of DNA damage monitoring20. Both large
and small deletions in p53 and PTCH1 genes can be
found in BCCs, which allow uncontrolled cell cycle pro-
gression, resistance to apoptosis, stimulated angiogene-
sis, replication of damaged DNA, therefore leading to
further carcinogenic mutations or gene amplification.
Clonal expansion of the initial mutated cell may also be
driven by sunlight21.
Furthermore, UV radiation induces the release of pro-
staglandins and cytokines by the keratinocytes. Among
the proinflammatory mediators released by keratino-
cytes, there are interleukin 1 and 6, while IL 10 and
TGF-b represent cytokines with immunosuppressive pro-
perties. Production of the fibroblast growth factor and
vascular endothelial growth factors results in angioge-
nesis, while inactivation of cellular adhesion molecules,
such as E-cadherin, facilitates local tissue destruction.
There is also increasing evidence that UV radiation
can affect extra-nuclear molecular targets located in the
cytoplasm and the cell membrane, including cell surface
receptors, kinases, phosphatases and transcription fac-
tors. UVB also alters antigen-presenting function of Lan-
gerhans cells that leads to immunosuppression9. Immuno-
suppressive drugs inhibit a physiologic function of the
immune system in recognition and destruction of clonal
expansion of precancerous lesions. In the absence of ex-
ogenous influences, mutant clones and pre-cancers tend
to regress. Chemotherapeutic agent 5-fluorouracil (5-
-FU) causes regression of dysplasia by elimination of ini-
tiated cells, perhaps through enhanced apoptosis. Con-
versely, retinoic acid temporarily suppresses clonal ex-
pansion21. The most important defense mechanisms in
the protection of human skin against UV radiation in-
volve melanin synthesis and active repair mechanisms.
Low pigmentation capacity in Caucasians and rare con-
genital defects in DNA repair are mainly responsible for
protection failures. The important function of nucleotide
excision DNA repair gene (NER) in protection against
skin cancer becomes obvious in rare genodermatosis
Xeroderma pigmentosum, where mutations in various
NER genes lead to multiple skin cancers19. When a muta-
tion confer apoptosis resistance, as p53 mutations do,
subsequent UV exposure will be more likely to kill nor-
mal cell than the mutated ones. The latter can expand
into a clone, where only a single cell requires additional
mutation.
Clinical Features of BCC
Clinically, BCC usually presents as a slowly expand-
ing, translucent, well-demarcated, pearly papule or nod-
ule with telangiectasias. It is usually located on the up-
per two-thirds of face, above the line connecting the
angle of the mouth and earlobe. However, several differ-
ent subtypes have been described8. Clinical variants of
BCC include nodular, ulcerated, pigmented, superficial,
sclerosing, cystic, fibroepithelioma, and Gorlin-Goltz syn-
drome22,17. Each varies in terms of clinical presentation,
histopathology and aggressive behavior. Dermatoscopy
as a relatively new, non-invasive diagnostic technique
may be helpful in diagnosis of BCC, since there are many
clinical presentations of BCC. Major dermatoscopic fea-
tures of BCC are: arborizing scattered vascular pattern,
teleangiectactic or atypical vessels, milky-pink background
and yellow or brown dots/globules23. However, a biopsy is
essential for the diagnosis and management of the skin
cancer. Histologically, the BCC is composed of basaloid
keratinocytes with characteristic peripheral palisading
of the large, relatively uniform, hyperchromatic nuclei
and retraction of the stroma around the tumor islands,
creating the pseudovascular spaces around the tumor
nests. Immunohistochemical studies are needed to ex-
clude melanoma24,25.
Treatment of BCC
The therapy of choice for the majority of primary
BCCs is surgical excision, which allows validation of sur-
gical margins. The choice of treatment is determined by
the size and location of the tumor, clinical subtype of
BCC, borders, immunosuppression, the patient’s age,
and patient’s comorbidities. Cryosurgery, electrosurgery,
radiotherapy, photodynamic therapy, topical cytotoxic
agents (5-fluorouracil) and immunomodulators (Imiqui-
mod cream) have been used to treat superficial BCC and
are advantageous for elderly patients, those wishing to
avoid invasive procedures and those with comorbidities.
These methods have been associated with higher recur-
rence rates of BCCs in comparison with surgical excision.
Microscopically controlled surgery or Mohs surgery is
the preferred treatment for sclerosing, recurrent, large
BCCs, poorly defined, and for those tumors in anatomi-
cal areas which necessitate tissue conservation, such as
the eyes, nose, lips and ears26. All patients with BCC re-
quire follow-up, regardless of the treatment modality
used as, as approximately 40% will develop a secondary
or recurrent BCC on the treated site within 5 years27.
The most important factor in prevention of the develop-
ment of BCC is the avoidance of excessive sun exposure
of the skin. Photoprotection is one of the fundamental
measures in the prevention of BCC. Dermatologists as
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well as other health professionals should educate their
patients on the use of sunscreen. The use of a highly ef-
fective broad-spectrum UVA and UVB sunscreen can
prevent the photo-induced immunosuppression and the
DNA damage that leads to the development of BCC.
Combination of UVA and UVB filters in the adequate sun
care products may offer a powerful protection against
UV-induced effects28,29. The health care providers should
also encourage the parents to apply sunscreen on their
children skin since it has been estimated that 75–80% of
total lifetime dose of solar radiation is received before the
age of twenty9.
Conclusion
Undoubtedly, skin exposure to the UV radiation is the
main cause of skin cancer, with BCC being the most fre-
quently occurring skin cancer as well as the most com-
mon malignancy in humans. The role of UV radiation in
the development of BCC has been proven and explained
trough several previously described mechanisms. There-
fore, due to extremely high incidence of BCC medical
professionals should be aware of the importance of the
public education on the etiology of this tumor and the im-
portance of the UV protection.
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ULOGA UV ZRA^ENJA U NASTANKU BAZEOCELULARNOG KARCINOMA
S A @ E T A K
Bazeocelularni karcinom (bazaliom, BCC) je neosporno naj~e{}i zlo}udni tumor ko`e i naj~e{}i zlo}udni tumor u
ljudi, a njegova u~estalost u stalnom je porastu. BCC je uglavnom bolest bijelaca, osobito osoba svijetle puti. Izlo`enost
ko`e UV zrakama je najva`niji i naj~e{}i uzrok nastanka BCC. Vjeruje se da UVB zrake kratke valne duljine (290–300
nm, zrake koje uzrokuju opekline) imaju zna~ajniju ulogu u nastanku BCC, nego UVA zrake duge valne duljine (320–400
nm, zrake koje uzrokuju tamnjenje ko`e). Razdoblje mirovanja od 20 do 50 godina je karakteristi~no vrijeme od UV
o{te}enja do klini~ke pojave BCC. Stoga, u ve}ini slu~ajeva BCC nastaje na kroni~no osun~anoj ko`i u odraslih osoba,
naj~e{}e u podru~ju glave i vrata. UVB zrake o{te}uju DNA i mehanizme njezinog popravka, te mijenjaju imunolo{ki
odgovor rezultiraju}i geneti~kim promjenama i nastankom tumora. UV zrake poti~u mutaciju p53 tumor-supresor gena.
Mutacije koje rezultiraju aktivacijom Hedgehog stani~nog signalnog puta, uklju~uju}i gene PTCH, Sonic hedgehog
(Shh) i Smoothened (Smo), imaju zna~ajnu ulogu karcinogenezi tumora ko`e. Epidemiolo{ke studije ukazuju na ve}u
u~estalost BCC u ekvatorijalnim, nego u polarnim krajevima. U ostale rizi~ne ~imbenike za nastanak BCC spadaju:
uporaba solarija, pozitivna obiteljska anamneza tumora ko`e, tip ko`e I i II, sklonost nastanku pjegavosti u djetinjstvu,
imunosupresija, prethodna radioterapija i kroni~na izlo`enost toksi~nim noksama, poput anorganskog arsena. Iako
vrlo rijetko metastazira, nelije~en BCC mo`e postati invazivan, lokalno agresivan, pa i smrtonosan. S obzirom na izu-
zetno visoku u~estalost BCC, lije~nici bi trebali biti svjesni va`nosti edukacije pu~anstva o etiologiji ovog tumora i
va`nosti UV za{tite.
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